Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5040501 | 6042311 | F | 5040501-9 | 20060427 | 20060428 | 20060630 | EXP | US-ROCHE-446191 | ROCHE | 53 | YR | M | Y | 96.4 | KG | 20060630 | MD | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5040501 | 1007431439 | PS | PEG-INTERFERON ALFA 2A (RO 25-8310) | 2 | SUBCUTANEOUS | B0085, B009201 | |||||
5040501 | 1007431440 | SS | PEG-INTERFERON ALFA 2A (RO 25-8310) | 2 | SUBCUTANEOUS | B0085, B009201 | |||||
5040501 | 1007431441 | SS | PEG-INTERFERON ALFA 2A (RO 25-8310) | 2 | SUBCUTANEOUS | B0085, B009201 | |||||
5040501 | 1007431442 | SS | RIBAVIRIN | 1 | ORAL | U5051, U6006 | 021511 | ||||
5040501 | 1007431443 | SS | RIBAVIRIN | 1 | ORAL | U5051, U6006 | 021511 | ||||
5040501 | 1007431444 | SS | RIBAVIRIN | 1 | ORAL | U5051, U6006 | 021511 | ||||
5040501 | 1007431445 | SS | LABETALOL HCL | 1 | UNKNOWN | ||||||
5040501 | 1007431446 | C | CALCIUM GLUCONATE | 1 | |||||||
5040501 | 1007431447 | C | ASPIRIN | 1 | |||||||
5040501 | 1007431448 | C | BACTRIM | 1 | REPORTED AS '160/WEEK' | ||||||
5040501 | 1007431449 | C | VICODIN | 1 | |||||||
5040501 | 1007431450 | C | VALCYTE | 1 | |||||||
5040501 | 1007431451 | C | TRAMADOL HCL | 1 | |||||||
5040501 | 1007431452 | C | MAGNESIUM | 2 | |||||||
5040501 | 1007431453 | C | LACTULOSE | 1 | |||||||
5040501 | 1007431454 | C | PREDNISONE | 1 | ON 03 JUNE 2006 DOSE WAS INCREASED TO 40 MG/DAY. | ||||||
5040501 | 1007431455 | C | ACIPHEX | 1 | |||||||
5040501 | 1007431456 | C | NYSTATIN | 1 | |||||||
5040501 | 1007431457 | C | CYCLOSPORINE | 1 | (USE MODIFIED) | ||||||
5040501 | 1007431458 | C | LASIX | 1 | |||||||
5040501 | 1007431459 | C | POTASSIUM | 2 | |||||||
5040501 | 1007431460 | C | PAXIL | 1 | |||||||
5040501 | 1007431461 | C | DESYREL | 1 | |||||||
5040501 | 1007431462 | C | CIPRO | 1 | |||||||
5040501 | 1007431463 | C | CARDIZEM | 1 | |||||||
5040501 | 1007431464 | C | LOPRESSOR | 1 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5040501 | 1007431439 | HEPATITIS C |
5040501 | 1007431442 | HEPATITIS C |
5040501 | 1007431445 | HYPERTENSION |
Outcome of event
Event ID | OUTC COD |
---|---|
5040501 | HO |
Reactions reported
Event ID | PT |
---|---|
5040501 | AUTOIMMUNE HEPATITIS |
5040501 | DISEASE RECURRENCE |
5040501 | HEPATITIS C |
5040501 | ORTHOSTATIC HYPOTENSION |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5040501 | 1007431439 | 20060303 | |||
5040501 | 1007431440 | 20060427 | |||
5040501 | 1007431441 | 20060531 | |||
5040501 | 1007431442 | 20060303 | |||
5040501 | 1007431443 | 20060427 | |||
5040501 | 1007431445 | 20060303 | |||
5040501 | 1007431446 | 20051118 | |||
5040501 | 1007431447 | 20051118 | 20060525 | 189 | DAY |
5040501 | 1007431448 | 20051118 | |||
5040501 | 1007431449 | 20051118 | |||
5040501 | 1007431450 | 20051121 | |||
5040501 | 1007431451 | 20051128 | |||
5040501 | 1007431452 | 20051205 | |||
5040501 | 1007431453 | 20051207 | |||
5040501 | 1007431454 | 20051210 | |||
5040501 | 1007431455 | 20051229 | |||
5040501 | 1007431456 | 20060130 | |||
5040501 | 1007431457 | 20060513 | |||
5040501 | 1007431458 | 20060301 | |||
5040501 | 1007431459 | 20060301 | |||
5040501 | 1007431460 | 20060413 | |||
5040501 | 1007431461 | 20060413 | |||
5040501 | 1007431462 | 20060425 | |||
5040501 | 1007431463 | 20060429 | |||
5040501 | 1007431464 | 20060429 |